Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Mineralys Therapeutics
MLYS
$2.88B
| $409K | ﹤0.01% |
31,700
+6,200
| +24% | +$80K |
|
2952
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
| $408K | ﹤0.01% |
+11,500
| New | +$408K |
|
2953
Pyxis Tankers
PXS
$29.6M
| $408K | ﹤0.01% |
85,601
+21,284
| +33% | +$101K |
|
2954
Anavex Life Sciences
AVXL
$823M
| $407K | ﹤0.01% |
+79,900
| New | +$407K |
|
2955
Five Star Bancorp
FSBC
$703M
| $407K | ﹤0.01% |
18,100
+736
| +4% | +$16.6K |
|
2956
Radiant Logistics
RLGT
$309M
| $406K | ﹤0.01% |
74,970
-21,430
| -22% | -$116K |
|
|
LABP
2957
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $406K | ﹤0.01% |
18,890
+7,630
| +68% | +$164K |
|
2958
Ark Restaurants
ARKR
$25.3M
| $403K | ﹤0.01% |
29,311
-900
| -3% | -$12.4K |
|
2959
Trevi Therapeutics
TRVI
$1.19B
| $403K | ﹤0.01% |
116,842
-425,858
| -78% | -$1.47M |
|
2960
Strata Skin Sciences
SSKN
$8.27M
| $402K | ﹤0.01% |
106,285
-460
| -0.4% | -$1.74K |
|
2961
USCB Financial Holdings
USCB
$350M
| $401K | ﹤0.01% |
35,211
-289
| -0.8% | -$3.29K |
|
2962
JPMorgan International Research Enhanced Equity ETF
JIRE
$8.47B
| $401K | ﹤0.01% |
+6,400
| New | +$401K |
|
|
DHC
2963
Diversified Healthcare Trust
DHC
$1.09B
| $398K | ﹤0.01% |
161,800
+118,164
| +271% | +$291K |
|
2964
NiSun International Enterprise Development Group
NISN
$17.4M
| $398K | ﹤0.01% |
75,468
-38,200
| -34% | -$201K |
|
2965
Corbus Pharmaceuticals
CRBP
$116M
| $397K | ﹤0.01% |
+10,123
| New | +$397K |
|
2966
Union Bankshares
UNB
$118M
| $397K | ﹤0.01% |
13,032
+500
| +4% | +$15.2K |
|
2967
Highway Holdings
HIHO
$7.92M
| $396K | ﹤0.01% |
188,415
-2,000
| -1% | -$4.2K |
|
2968
First Trust Dorsey Wright Focus 5 ETF
FV
$3.75B
| $395K | ﹤0.01% |
+6,900
| New | +$395K |
|
2969
Cellectar Biosciences
CLRB
$16.9M
| $392K | ﹤0.01% |
+3,283
| New | +$392K |
|
2970
FibroGen
FGEN
$50.3M
| $391K | ﹤0.01% |
6,660
-20,676
| -76% | -$1.21M |
|
2971
Emerson Radio
MSN
$9.05M
| $391K | ﹤0.01% |
737,388
-5,800
| -0.8% | -$3.08K |
|
2972
Apogee Enterprises
APOG
$941M
| $390K | ﹤0.01% |
6,583
-7,500
| -53% | -$444K |
|
|
EDN
2973
Edenor
EDN
$789M
| $390K | ﹤0.01% |
22,024
+8,124
| +58% | +$144K |
|
2974
Acushnet Holdings
GOLF
$4.47B
| $389K | ﹤0.01% |
5,900
+1,500
| +34% | +$98.9K |
|
2975
Vanguard Real Estate ETF
VNQ
$35B
| $389K | ﹤0.01% |
+4,500
| New | +$389K |
|